Protocol No.: EAA173

Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma
Principal Investigator
Veltri, Lauren
Phase
III
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kathryn Oliverio, LPN
Research Specialist
Phone: +1 304-293-7374

View on ClinicalTrials.gov